HI SB541

Simplifies the definition of "manufactured cannabis product" in Hawaii Revised Statutes by replacing a detailed list with a reference to department specifications in section 329D-10.

Changes "transdermal patches" to "transdermal devices as approved by the department" to allow non-patch devices that deliver cannabis through the skin.

Establishes ten categories of allowable medical cannabis products: capsules, lozenges, pills, oils and oil extracts, tinctures, ointments and skin lotions, transdermal devices, pre-filled aerosol containers, pulmonary administration devices, and other products specified by the department.

Defines requirements for pulmonary administration devices, including inert heating materials (glass, ceramic, or stainless steel), temperature control to prevent combustion, and use with single-use sealed containers without nicotine or tobacco products.

Takes effect July 1, 2050.